-
The case is set to test states' conflicting abortion laws, a battle that could rise to the U.S. Supreme Court.
-
A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide. The states of Idaho, Kansas and Missouri can now move ahead with their efforts in U.S. District Court in Amarillo, where a nominee of former President Donald Trump is the only judge.
-
This case sets up a legal battle between Texas’ near-total abortion ban and New York’s shield law that protects doctors from out-of-state prosecution.
-
More than half of people who've used telehealth come from states like Texas that have banned or severely limited access to abortion.
-
Senate Majority Leader Chuck Schumer, D-NY, has accused a federal district court that spans North Texas and the Panhandle of assigning cases in a way that allows cases filed in certain areas to consistently land in front of judges who may be sympathetic to a plaintiff or defendant's goals.
-
At issue is the FDA's regulatory power to approve drugs and continually evaluate their safety — a system that until now has been widely viewed as the gold standard for both safety and innovation
-
A Texas federal judge revoked FDA approval of the self-managed abortion drug in April.
-
The Supreme Court has left the case in the hands of the 5th U.S. Circuit Court of Appeals, which has scheduled oral arguments in the case for May 17.
-
Supreme Court Justice Samuel Alito has placed a hold on a lower court ruling that restricts access to the abortion drug mifepristone until Wednesday night.
-
A Texas federal judge revoked long-standing FDA approval of a drug used to self-manage abortions and miscarriages. Abortion rights supporters say that will have wide-ranging repercussions for Texans, who already face extreme barriers to accessing reproductive care.